Last checked at 15 Sep 2016 07:00
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR)
Tekcapital plc
("Tekcapital")
Acquisition of Medical Device Licence
Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that Belluscura Limited ("Belluscura"), has acquired the exclusive licence and related manufacturing assets for the distribution and sale of the Wire CaddyTM, a proprietary medical device, from Stryker Corporation.
The Wire Caddy is an innovative wire management system that provides lubrication and organization during multi-wire, multi-exchange operating room cases such as cardiology interventions, uterine fibroid embolizations and tibial angioplasties.
The Wire Caddy provides unobtrusive positioning around the patient, allowing immediate access to wires when needed, but keeping them out of the way when not in use. The patented system was developed by a leading interventional radiologist. The device is cleared for sale in the U.S. and previously achieved commercial sales in over 100 hospitals. The consideration for the licence acquisition includes a modest up-front cash payment and the agreement for Belluscura to pay royalties on future product sales. The product is protected by two issued patents.
Tekcapital holds 74.44% of the share capital of Belluscura.
Dr. Clifford M. Gross, Executive Chairman of Tekcapital, commented: "We are very pleased to announce that Belluscura has acquired the exclusive licence to the Wire Caddy and is executing its model to acquire and market unique medical devices. Belluscura's mission is to provide premium, proprietary medical devices at affordable prices."
For further information, please contact:
Tekcapital Plc | +1 305 200 3450 Ext 305 | |
| Clifford M. Gross, Ph.D. | info@tekcapital.com |
|
| |
Allenby Capital Limited (Nominated Adviser & Joint Broker) | +44 (0)20 3328 5656 | |
Jeremy Porter / Alex Brearley |
| |
|
| |
Optiva Securities Limited (Joint Broker) | +44 (0) 20 3137 1904 | |
Jeremy King / Vishal Balasingham | jeremy.king@optivasecurities.com | |
|
| |
Walbrook PR Ltd | +44 (0) 20 7933 8780 | |
Paul Cornelius / Paul McManus / Helen Cresswell | tekcapital@walbrookpr.com | |
|
|
|
About Tekcapital plc - The World's Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com